107 related articles for article (PubMed ID: 21747326)
1. Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation.
Ashokkumar C; Shapiro R; Tan H; Ningappa M; Elinoff B; Fedorek S; Sun Q; Higgs BW; Randhawa P; Humar A; Sindhi R
Transplantation; 2011 Aug; 92(4):433-8. PubMed ID: 21747326
[TBL] [Abstract][Full Text] [Related]
2. Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation.
Ashokkumar C; Gupta A; Sun Q; Ningappa MB; Higgs BW; Mazariegos G; Fazzolare T; Remaley L; Soltys K; Bond G; Abu-Elmagd K; Sindhi R
Surgery; 2009 Aug; 146(2):166-73. PubMed ID: 19628070
[TBL] [Abstract][Full Text] [Related]
3. Renal allograft surveillance with allospecific T-cytotoxic memory cells.
Rohan VS; Soliman KM; Alqassieh A; Alkhader D; Patel N; Nadig SN
Ren Fail; 2020 Nov; 42(1):1152-1156. PubMed ID: 33203287
[TBL] [Abstract][Full Text] [Related]
4. Proliferative alloresponse of T cytotoxic cells identifies rejection-prone children with small bowel transplantation.
Ashokkumar C; Gupta A; Sun Q; Higgs BW; Ningappa M; Snyder S; Johnson M; Mazariegos G; Soltys K; Bond G; Abu-Elmagd K; Sindhi R
Transplantation; 2010 Jun; 89(11):1371-7. PubMed ID: 20458270
[TBL] [Abstract][Full Text] [Related]
5. Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes.
Ashokkumar C; Sun Q; Ningappa M; Higgs BW; Mazariegos G; Zeevi A; Sindhi R
Transplantation; 2015 Jan; 99(1):164-70. PubMed ID: 25531894
[TBL] [Abstract][Full Text] [Related]
6. Allospecific CD154+ B cells associate with intestine allograft rejection in children.
Ashokkumar C; Bentlejewski C; Sun Q; Higgs BW; Snyder S; Mazariegos GV; Abu-Elmagd K; Zeevi A; Sindhi R
Transplantation; 2010 Dec; 90(11):1226-31. PubMed ID: 20881665
[TBL] [Abstract][Full Text] [Related]
7. Allospecific CD154 + T-cytotoxic memory cells as potential surrogate for rejection risk in pediatric intestine transplantation.
Sindhi R; Ashokkumar C; Higgs BW; Gilbert PB; Sun Q; Ranganathan S; Jaffe R; Snyder S; Ningappa M; Soltys KA; Bond GJ; Mazariegos GV; Abu-Elmagd K; Zeevi A
Pediatr Transplant; 2012 Feb; 16(1):83-91. PubMed ID: 22122074
[TBL] [Abstract][Full Text] [Related]
8. Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children.
Ashokkumar C; Soltys K; Mazariegos G; Bond G; Higgs BW; Ningappa M; Sun Q; Brown A; White J; Levy S; Fazzolare T; Remaley L; Dirling K; Harris P; Hartle T; Kachmar P; Nicely M; OʼToole L; Boehm B; Jativa N; Stanley P; Jaffe R; Ranganathan S; Zeevi A; Sindhi R
Transplantation; 2017 Jan; 101(1):131-140. PubMed ID: 26950712
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H).
Gallon L; Gagliardini E; Benigni A; Kaufman D; Waheed A; Noris M; Remuzzi G
Clin J Am Soc Nephrol; 2006 May; 1(3):539-45. PubMed ID: 17699257
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of acute renal allograft rejection by analyzing whole blood mRNA expression of lymphocyte marker molecules.
Alakulppi NS; Kyllönen LE; Partanen J; Salmela KT; Laine JT
Transplantation; 2007 Mar; 83(6):791-8. PubMed ID: 17414714
[TBL] [Abstract][Full Text] [Related]
11. Pretransplant low CD3+CD25high cell counts or a low CD3+CD25high/CD3+HLA-DR+ ratio are associated with an increased risk to acute renal allograft rejection.
Hueso M; Mestre M; Benavente Y; Bas J; Grinyó JM; Navarro E
Transplantation; 2011 Sep; 92(5):536-42. PubMed ID: 21849930
[TBL] [Abstract][Full Text] [Related]
12. Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation.
Ashokkumar C; Talukdar A; Sun Q; Higgs BW; Janosky J; Wilson P; Mazariegos G; Jaffe R; Demetris A; Dobberstein J; Soltys K; Bond G; Thomson AW; Zeevi A; Sindhi R
Am J Transplant; 2009 Jan; 9(1):179-91. PubMed ID: 18976293
[TBL] [Abstract][Full Text] [Related]
13. Increased monocyte expression of sialoadhesin during acute cellular rejection and other enteritides after intestine transplantation in children.
Ashokkumar C; Gabriellan A; Ningappa M; Mazariegos G; Sun Q; Sindhi R
Transplantation; 2012 Mar; 93(5):561-4. PubMed ID: 22249367
[TBL] [Abstract][Full Text] [Related]
14. Identification of peripheral CD154
Boix F; Legaz I; Minhas A; Alfaro R; Jiménez-Coll V; Mrowiec A; Martínez-Banaclocha H; Galián JA; Botella C; Moya-Quiles MR; Sanchez-Bueno F; Robles R; de la Peña-Moral J; Ramirez P; Pons JA; Minguela A; Muro M
Clin Exp Immunol; 2021 Feb; 203(2):315-328. PubMed ID: 33025622
[TBL] [Abstract][Full Text] [Related]
15. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
[TBL] [Abstract][Full Text] [Related]
16. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.
Heeger PS; Greenspan NS; Kuhlenschmidt S; Dejelo C; Hricik DE; Schulak JA; Tary-Lehmann M
J Immunol; 1999 Aug; 163(4):2267-75. PubMed ID: 10438971
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection.
Mengel M; Mueller I; Behrend M; von Wasielewski R; Radermacher J; Schwarz A; Haller H; Kreipe H
Transpl Int; 2004 Jul; 17(6):293-300. PubMed ID: 15221125
[TBL] [Abstract][Full Text] [Related]
18. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
Kuypers DR; Vanrenterghem Y
Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
